Samrat Pharmachem informs about compliance certificate

12 Oct 2022 Evaluate
Samrat Pharmachem has informed that it enclosed compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022, received from Link Intime India.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

210.35 -3.05 (-1.43%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×